Personalized Medicine

Cancer therapy that is moving away from treating a type of cancer to treating different marker profiles regardless of the cancer type.


The host cellular protein that is responsible for preventing reovirus replication. Tumor cells that lack the activity of PKR are susceptible to reovirus infection and eventual cell death.